Kairos Pharma, Ltd.

KAPAAMEXUSD
0.31 USD
0.03 (8.80%)AT CLOSE (11:59 AM EDT)
0.30
0.01 (3.19%)
POST MARKET (AS OF 08:15 PM EDT)
Post Market
AS OF 08:15 PM EDT
0.30
0.01 (3.19%)
🔴Market: CLOSED

KAPA is currently priced at $0.31. Technicals currently rate "Strong Sell" while our fundamental analysis reads "Neutral". Notable factors include a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.

Technical & fundamental data as of Jul 17, 2026.

Open?$0.30
High?$0.33
Low?$0.28
Prev. Close?$0.34
Volume?2.9M
Avg. Volume?2.9M
VWAP?$0.30
Rel. Volume?0.99x
Bid / Ask
Bid?$0.29 × 100
Ask?$0.33 × 11.0K
Spread?$0.04
Midpoint?$0.31
Valuation & Ratios
Market Cap?6.6M
Shares Out?21.4M
Float?13.4M
Float %?62.8%
P/E Ratio?N/A
P/B Ratio?1.25
EPS?-$0.27
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Kairos Pharma Ltd is a clinical-stage biopharmaceutical company. The company is engaged in therapeutics for cancer patients that are designed to overcome key hurdles in immune suppression and drug resistance. These therapeutics include antibodies and small molecules for the treatment of prostate cancer, lung cancer, breast cancer, and glioblastoma. The product portfolio of the company consists of Pre-clinical or clinical-trial stage drug candidates, Therapeutic agents, and other technologies for treating diseases.
Employees
1
Market Cap
7.3M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2024-09-16
Address
2355 WESTWOOD BLVD. #139
LOS ANGELES, CA 90064
Phone: 818-404-5541
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bearish(-3/3)
Medium-Term (Wave)? Bearish(-3/3)
Short-Term (Ripple)? Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
63
Momentum?
50
Short Sent.?
70
Piotroski F-Score?0/9Weak
Altman Z-Score?2.75Grey
Confidence?41%Low
Full Fundamental Analysis →
Short InterestLow
Short % of Float?1.16%Low
Short Interest?155.9K
Days to Cover?1.1
Free Float13.4M
Avg Daily Volume140.9K
Settlement Date2026-06-30
Financial Health
Current Ratio?10.31Strong
Quick Ratio?10.31Strong
Cash Ratio?8.53Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A
P/B?
Peers
100
S&P
92
1.25CHEAP
P/S?
N/A
P/FCF?
N/A
EV/EBITDA?
S&P
97
-0.9CHEAP
EV/Sales?
N/A
Returns & Efficiency
ROE?
S&P
3
-109.9%WEAK
ROA?
S&P
3
-101.6%WEAK
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$3.0M
Fundamentals ratios updated end of day